Renew-Cera(Synthetic/Vial)

The optimum ratio of silicon-containing hydroxyapatite (Si-HA, 60%) to β-tricalcium phosphate (β-TCP, 40%)
* No risk of immune rejection or pathogenic substance transfer.
* Due to its large surface area, it has excellent progenitor cell activity (72% porosity).
* Uses coral, similar to human spongy bone, as its main raw material. * Bone formation in 5-6 months
[Indications]
· Alveolar ridge defect · Extraction defect · Sinus augmentation · Periodontal defect[Specifications]
Particle sizes: Vial Type(0.3-0.5mm/0.5-1.0mm/1.0-2.0mm) Available Sizes: 0.25g/0.5g/1.0g/2.0g